Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience.

Authors :: Lee Chuy K
Oikonomou EK
Postow MA
Callahan MK
Chapman PB
Shoushtari AN
Neilan TG
Fradley MG
Ramanathan LV
Wolchok JD
Steingart RM
Gupta D
Source :: The oncologist [Oncologist] 2019 May; Vol. 24 (5), pp. e196-e197. Date of Electronic Publication: 2019 Mar 25.
Publication Year :: 2019
Abstract: This letter to the editor describes myocarditis screening among patients undergoing combination immune checkpoint inhibitor therapy, in light of the consensus document from the Checkpoint Inhibitor Safety Working Group.<br />Competing Interests: Disclosures of potential conflicts of interest may be found at the end of this article.

Subjects :: Aged
Humans
Middle Aged
Myocarditis etiology
Immunotherapy methods
Melanoma complications
Melanoma drug therapy
Myocarditis diagnosis

Full Text Access

Tools